Thomson, Emma C, Rosen, Laura E, Shepherd, James G, Spreafico, Roberto, Filipe, Ana da Silva, Wojcechowskyj, Jason A, Davis, Chris, Piccoli, Luca, Pascall, David J, Dillen, Josh et al (show 56 more authors)
(2021)
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
CELL, 184 (5).
1171-+.
ISSN 0092-8674, 1097-4172
Abstract
SARS-CoV-2 can mutate and evade immunity, with consequences for efficacy of emerging vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-CoV-2 spike (S) receptor binding motif (RBM) is a highly variable region of S and provide epidemiological, clinical, and molecular characterization of a prevalent, sentinel RBM mutation, N439K. We demonstrate N439K S protein has enhanced binding affinity to the hACE2 receptor, and N439K viruses have similar in vitro replication fitness and cause infections with similar clinical outcomes as compared to wild type. We show the N439K mutation confers resistance against several neutralizing monoclonal antibodies, including one authorized for emergency use by the US Food and Drug Administration (FDA), and reduces the activity of some polyclonal sera from persons recovered from infection. Immune evasion mutations that maintain virulence and fitness such as N439K can emerge within SARS-CoV-2 S, highlighting the need for ongoing molecular surveillance to guide development and usage of vaccines and therapeutics. Epidemiological, clinical, molecular, and structural characterization of the N439K mutation in the SARS-CoV-2 spike receptor binding motif demonstrates that it results in similar viral fitness compared to wild-type while conferring resistance against some neutralizing monoclonal antibodies and reducing the activity of some polyclonal antibody responses.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | ISARIC4C Investigators, COVID-19 Genomics UK (COG-UK) Consortium, Humans, Antibodies, Viral, Phylogeny, Virulence, Mutation, Genetic Fitness, Immune Evasion, Antibodies, Neutralizing, Spike Glycoprotein, Coronavirus, COVID-19, Angiotensin-Converting Enzyme 2, SARS-CoV-2 |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 26 Feb 2021 16:58 |
| Last Modified: | 16 Jun 2026 08:07 |
| DOI: | 10.1016/j.cell.2021.01.037 |
| Open Access URL: | https://doi.org/10.1016/j.cell.2021.01.037 |
| Related Websites: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3116128 |
| Disclaimer: | The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate. |

Altmetric
Altmetric